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ABSTRACT: Mental disorders have a complex etiology re-
sulting from interactions between multiple genetic risk factors
and stressful life events. Orphan G protein-coupled receptor
50 (GPR50) has been identiﬁed as a genetic risk factor for
bipolar disorder and major depression in women, and there is
additional genetic and functional evidence linking GPR50 to
neurite outgrowth, lipid metabolism, and adaptive thermogenesis
and torpor. However, in the absence of a ligand, a speciﬁc
function has not been identiﬁed. Adult GPR50 expression has
previously been reported in brain regions controlling the HPA
axis, but its developmental expression is unknown. In this
study, we performed extensive expression analysis of GPR50
and three protein interactors using rt-PCR and immunohistochemistry in the developing and adult mouse brain. Gpr50 is
expressed at embryonic day 13 (E13), peaks at E18, and is predominantly expressed by neurons. Additionally we identiﬁed novel
regions of Gpr50 expression, including brain stem nuclei involved in neurotransmitter signaling: the locus coeruleus, substantia
nigra, and raphe nuclei, as well as nuclei involved in metabolic homeostasis. Gpr50 colocalizes with yeast-two-hybrid interactors
Nogo-A, Abca2, and Cdh8 in the hypothalamus, amygdala, cortex, and selected brain stem nuclei at E18 and in the adult. With
this study, we identify a link between GPR50 and neurotransmitter signaling and strengthen a likely role in stress response and
energy homeostasis.
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Psychiatric disorders are a major health problem in the worldtoday. One in four people are aﬀected by mental disorders
during their lives, according to the World Health Organization.1
Psychiatric illness results from the interaction between genetic
and environmental risk factors. There is a strong genetic com-
ponent, as is clear from family, twin, and adoption studies.2
Recently, G protein-coupled receptor 50 (GPR50) was identiﬁed
as a risk gene for bipolar disorder and major depression in
Scottish women.3,4 GPR50, previously known as the melatonin-
related receptor, is the mammalian ortholog of the melatonin
1c receptor (Mel1c).5 Despite a 45% sequence identity to
melatonin receptors MT1 and MT2, it does not bind melatonin
or any other ligand and therefore remains an orphan receptor
without a clear function.6,7 We have recently reported the
results of a yeast two-hybrid study (Y2H), identifying
interactors with the relatively large GPR50 C-terminal domain.8
Interactors can be grouped into two functional classes by gene
ontology: neural development and sterol metabolism, indicat-
ing a likely role in these mechanisms. In addition, we showed
that GPR50 has a dramatic eﬀect on the neurite outgrowth,
supporting a likely role in neural development.8 Although the
list of interactors includes several interesting protein partners,
we know little about where and when these proteins could
interact and what function the interactions would have.
Functional evidence for a link to lipid metabolism is
indicated by the association of GPR50 sequence variants with
elevated triglycerides and lower circulating HDL-cholesterol
levels,9 and Gpr50 knockout mice show hyperactivity, higher
metabolic rates, and resistance to obesity when fed on a high
energy diet.10 A recent study identiﬁed a role for GPR50 in
adaptive thermogenesis and torpor,11 the body’s response to
food shortage. The absence of Gpr50 resulted in a rapid onset
of torpor in mice and was associated with a diminished
responsiveness to leptin, and a reduction in the expression of
hypothalamic thyrotropin-releasing hormone (TRH). Addi-
tionally, there appears to be a function for GPR50 in modifying
MT receptor signaling. The receptors are shown to
heterodimerize and GPR50 can also inhibit MT1 signaling via
its intracellular C-terminal domain.12
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GPR50 expression has previously been found in the
hypothalamus, the pituitary, and the adrenal, in humans,
rodents, and sheep, suggesting a role in the HPA axis and
neuroendocrine system.13−15 GPR50 is thought to be expressed
by tanycytes, a glial cell type lining ependyma of the third
ventricle, in a seasonal pattern.16 Nothing is known however
about its developmental expression.
In order to investigate the spatial and temporal expression
patterns of GPR50 and its interactors as identiﬁed by Y2H, we
performed rt-PCR and immunohistochemistry in the develop-
ing and adult mouse brain. We have previously conﬁrmed the
interaction of neurite outgrowth inhibitor Nogo-A with
GPR50.8 Here we choose to also investigate the interaction
with and coexpression of Y2H interactors calcium-dependent
cell−cell adhesion molecule cadherin 8 (CDH8) and the ATP-
binding cassette transporter-2 (ABCA2), because of the known
involvement of CDH8 and other cadherins in brain develop-
ment17 and a role of ABCA2 in maintaining homeostasis of
cholesterol, steroids, and lipids.18,19 rt-PCR on 48 regional
samples at developmental stages E13, E15, E18, day 7, and
week 5 was followed up by immunohistochemistry in the E18
and adult mouse brain using protein-speciﬁc antibodies and
markers.
■ RESULTS AND DISCUSSION
Subcellular Localization of GPR50, CDH8, and ABCA2.
To investigate where GPR50 is coexpressed with CDH8 and
ABCA2, immunocytochemistry and subcellular fractionation
experiments were performed. In addition, coimmunoprecipita-
tions were performed to investigate whether GPR50 interacts
with CDH8 and ABCA2 under overexpressed conditions. In
neuroblastoma cells, overexpressed GPR50 colocalizes with
exogenous ABCA2 in the endosomal and lysosomal compart-
ments and with exogenous CDH8 in the plasma membrane
(Figure 1A). Coimmunoprecipitations in HEK293T cells show
that overexpressed ABCA2 and CDH8 coprecipitate with
GPR50 (Figure 1B). Subcellular fractionation experiments of
adult mouse brain have previously shown endogenous
expression and enrichment of Gpr50 and Nogo-A in the pre-
and postsynaptic density fractions. These proteins are also
present, but less enriched, in the crude synaptosome (P2) and
light membrane (P3, includes ER, golgi, endolysosome)
fractions.8 In a similar experiment, Cdh8 and Abca2 were
both detected in the light membrane, crude synaptosome, and
synaptosomal fraction (Figure 1C). Gpr50 does not appear to
be expressed in myelin, as is known for Nogo-A,20 suggesting it
is not expressed by oligodendrocytes.
Figure 1. Interactions and subcellular localization of GPR50, CDH8, and ABCA2. (A) SH-SY5Y cells were cotransfected with GPR50 and
ABCA2 or CDH8 and costained with endosomal marker EEA1, lysosomal marker LAMP1, or plasma membrane marker pan-cadherin.
GPR50 colocalizes with ABCA2 in the endosome and lysosome and with CDH8 on the cell membrane. Scale bars: 50 μm. (B) HEK293T
cells were transfected with GPR50, CDH8, ABCA2 or cotransfected with GPR50 and CDH8 or GPR50 with ABCA2. Lysates were
immunoprecipitated with GPR50 antibody. Western blots were probed with CDH8 or ABCA2 revealing coimmunoprecipitations of both
proteins with GPR50. (C) Western blot after subcellular fractionation of 10 adult female mouse brains. CDH8 is enriched in the
presynaptic membrane fraction (LP1) and in the postsynaptic PSD1 and PSD2 fractions. ABCA2 is expressed in low levels in the
synaptosome but not detected in the speciﬁc synaptosomal fractions. Pre- and postsynaptic fractions are marked by expression of
synaptophysin and PSD-95.
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Cdh8 was found to be enriched in the presynaptic membrane
fraction and in the postsynaptic density fractions (Figure 1C), in
line with its previously detected localization at synaptic junctions
and suggested role in cell−cell adhesion at synaptic contacts.21
ABCA2 was reported to localize to intracellular lysosomal fractions,
but may also relocate to other cell membrane compartments.19
This indicates GPR50, CDH8, and ABCA2 may be interaction
partners at the synapse or in internal membranes.
Developmental Expression of Gpr50 and Interactors
by rt-PCR. To determine where and when GPR50 is expressed
and available to interact with its partners, rt-PCR was
performed on a developmental mouse brain panel (Origene)
covering 48 regional samples over ﬁve time points, E13, E15,
E18, P7, and week 5. Data was normalized against four
housekeeping genes (β-actin, Tbp, Hmbs, and cyclophilin) with
varying levels of expression (Ct value, Supporting Information
Table 1) to reﬂect the diﬀerence in expression levels between
our genes-of-interest (Supporting Information Table 1).
Relative normalized expression of Gpr50, Nogo-A, Cdh8, and
Abca2 is shown in Figure 2. Gpr50 mRNA was detected in low
levels from E13, peaked at E18, and increased again at week 5.
At most developmental time points, Gpr50 shows a restricted
expression pattern with highest expression in thalamus, in
hypothalamus (diencephalon), and in the midbrain, pons, and
medulla (mesencephalon, rhombencephalon). Nogo-A mRNA
expression is extensive and constant and was detected
throughout all regions and time points. Cdh8 expression is
relatively constant but did show an increase in the posterior
regions at E18 and frontal regions at day 7. Abca2 expression is
lower during early development and increases at week 5. The
results suggest an increased expression of the genes around E18
and/or at 5 weeks, indicating possible coregulation.
To test this Spearman correlations (r) were performed of the
overall data (between the genes for all regions and ages, using
the above genes plus Nogo-pan (detecting Nogo-A,-B, and -C),
Gpr50 correlates signiﬁcantly with Abca2 (Spearman’s r (95%
conﬁdence interval); p-value): (r = 0.43 (0.15−0.64); p =
0.0028). Other signiﬁcant correlations are Nogo-pan with Cdh8
(r = 0.39 (0.11−0.61); p = 0.0068), Nogo-pan with Abca2 (r =
0.40 (0.12−0.62); p = 0.0058), and Nogo-A with Cdh8 (r = 0.32
(0.03−0.56); p = 0.0268). As expected, Nogo-pan correlates
with Nogo-A (r = 0.37 (0.09−0.60); p = 0.0097).
Because Gpr50 shows increased expression around E18,
Spearman correlations were calculated for age E18 only. At this
time point, Gpr50 correlates signiﬁcantly with Cdh8 (r =
0.64(0.09−0.89); p = 0.024) and again with Abca2 (r =
0.71(0.20−0.91); p = 0.0102). Other signiﬁcant correlations were
found between Nogo-pan and Abca2 (r = 0.71 (0.20−0.91); p =
0.0102) and between Cdh8 and Abca2 (r = 0.68 (0.15−0.90); p =
0.0153). By contrast, no signiﬁcant correlations were found at
week 5. These results may indicate possible coregulation between
GPR50 and ABCA2 overall and CDH8 at E18 only.
Gpr50 is Expressed in Hypothalamic and Brainstem
Nuclei. Subregional expression and coexpression of our
proteins of interest at the cellular level was investigated by
immunohistochemistry in mouse brain at E18, when Gpr50 was
found to be most highly expressed, and in the adult. In
accordance with the rt-PCR results, the coronal planes
containing the hypothalamus and third ventricle, the midbrain,
pons, medulla, and cerebellum were investigated (see Methods
for details). Both chromogenic and ﬂuorescent detection
methods were used. Control experiments show absence of
signal using a GPR50 blocking peptide, indicating speciﬁc
staining of the antibody (Supporting Information Figure 1A).
The relative normalized expression levels of Gpr50 mRNA as
measured by rt-PCR and levels of protein expression as
detected by immunohistochemistry in E18 and adult mouse
brain are summarized in Table 1. In agreement with previous
reports14 and with the rt-PCR data, Gpr50 is highly expressed
in the hypothalamus around the third ventricle, the amygdala,
amygdalar or piriform cortex, and the entorhinal and
somatosensory cortices. Hippocampal expression of Gpr50
was detected on the midbrain level in the adult brain only, in
the polymorph layer of the dentate gyrus, which is the primary
target for noradrenergic, serotonergic, and cholinergic input
to the hippocampus.22 At the midbrain level, Gpr50 is also
expressed in the cortex and in agreement with the rt-PCR data
the ventral pons. Gpr50 appeared to be moderately expressed
in the ventral midbrain, in the substantia nigra pars compacta.
In more posterior regions in the brain, Gpr50 expression is
found at low levels in the midbrain and pontine raphe nuclei,
the cortex, and the superior colliculus. In the pons and medulla,
Gpr50 is moderate to highly expressed in several brainstem
nuclei, including strong expression in the locus coeruleus.
Gpr50 expression is also found in the inferior colliculus and in
low levels in the Purkinje cell layer of the cerebellum (Table 1).
There was much agreement in protein expression levels as
detected by chromogenic and ﬂuorescent methods except for
Figure 2. Real-time quantitative rt-PCR on Origene mouse developmental panel with 48 regional brain samples from ﬁve developmental stages.
Relative normalized expression values of Gpr50, Nogo-A, Nogo-C, Cdh8 and Abca2 normalized to β-Actin, Tbp, Hmbs, and cyclophilin B.
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the substantia nigra, which showed clearer Gpr50 expression
when using a HRP secondary and DAB than when using
ﬂuorescent secondary antibodies (Supporting Information
Figure 2). This perhaps reﬂects the greater sensitivity of the
DAB method.23
Gpr50 Expression in Neurons. Few studies have
investigated the speciﬁc cell type(s) that express GPR50. In
the ependyma of the third ventricle, Gpr50 is thought to be
expressed by tanycytes as determined by location, morphology,
and colabeling with vimentin or Glut1,11,16,24 and by neurons in
the dorsomedial hypothalamus.24 As we identiﬁed novel
regions of Gpr50 expression, we carried out immunoﬂuo-
rescence colocalization of Gpr50 with cell type markers NeuN
(mature neurons), GFAP (astrocytes), and O4 (oligodendro-
cytes). Gpr50 colocalizes with NeuN the cortex, midbrain,
superior colliculus, pons, hippocampus, and brain stem nuclei
(Figure 3A−J). In the locus coeruleus, colocalization between
Gpr50 and NeuN was not as clear (Figure 3J) but weak NeuN
staining in locus coeruleus neurons has been reported
previously.25 Gpr50 does not colocalize with GFAP, O4, or
vimentin in any of these regions (not shown). The increased
expression of Gpr50 at embryonic stages also suggests a
predominant expression by neurons.
Gpr50 Expression in Monoaminergic Neurons. The
apparent expression of Gpr50 in several brain stem nuclei of
behavioral importance is intriguing and was further investigated
by colabeling of Gpr50 with 5-HT (serotonergic marker),
tyrosine hydroxylase (TH, dopaminergic and noradrenergic
marker), and dopamine beta hydroxylase (DBH, noradrenergic
neuronal marker) in the adult mouse brain (Figure 4A−E). The
strongest Gpr50 expression was detected in the locus coeruleus,
where clear colocalization with DBH was detected (Figure 4A).
Gpr50 is only expressed in low levels in the nucleus raphe
magnus where it colocalizes with 5-HT (Figure 4B). Other
areas of 5-HT expression including the pontine gray and
the substantia nigra also showed colocalization with Gpr50
(Figure 4C, D). Gpr50 staining by immunoﬂuorescence was
weaker in the substantia nigra than with DAB (Table 1,
Supporting Information Figure 2). Colocalization with 5-HT
(Figure 4D) and TH (Figure 4E) in this area was therefore
present but not strong.22 These brain stem nuclei are highly
interconnected with other areas in the brain, including the
hypothalamus,26 and the neuromodulatory and behavioral
properties of the monoaminergic neurotransmitters have been
well researched. Dopamine plays a role in movement, reward,
and addiction; serotonin is implicated in appetite, mood,
and anxiety; and noradrenaline is involved in ﬁght-or-ﬂight
reaction, stress, and depression. In the absence of a ligand
for Gpr50, its expression in the brainstem and colocalization
with noradrenergic, dopaminergic, and serotonergic markers is
Table 1. Expression Levels of Gpr50 in the Mouse Braina
region
Gpr50
mRNA
Gpr50
protein Nogo-A Cdh8 Abca2
E18
frontal cortex 0.637 +++ Y Y N
posterior cortex 0.394 +++ Y Y N
entorhinal cortex 0.202 × × × ×
olfactory bulb 0.285 × × × ×
hippocampus 0.198 - N N N
striatum 0.36 - N N N
thalamus 2.57 ++ N N N
hypothalamus 7.015 +++ N Y N
midbrain 1.768 + N N N
pons 0.906 + Y Y N
medulla 1.138 ++ Y Y N
spinal cord 1.559 × × × ×
week 5/10
frontal cortex 0.51 × × × ×
posterior cortex 0.323 × × × ×
motor cortex + Y N Y
somatosensory cortex ++ Y N Y
visual cortex ++ Y N Y
entorhinal cortex 2.306 ++ Y N Y
piriform cortex ++ Y N Y
olfactory bulb 2.352 × × × ×
hippocampus 0.939
dentate gyrus medial blade
polymorph layer
+ N N N
hippocampus other - N N N
amygdala ++ Y Y Y
striatum 0.445 - N N N
thalamus 2.134 ++ N N N
hypothalamus 1.906
suprachiasmatic nucleus ++ N N N
region
Gpr50
mRNA
Gpr50
protein Nogo-A Cdh8 Abca2
week 5/10
subparaventricular zone ++ Y N N
ependyma of third ventricle +++ N N Y
dorsomedial hypothalamus ++ Y N N
ventromedial hypothalamus ++ N Y Y
lateral hypothalamus + Y N N
arcuate nucleus ++ Y N Y
median eminence ++ N N Y
cerebellum 0.169
Purkinje cell layer + N N N
cerebellum other - N N N
midbrain 1.163
superior colliculus ++ Y N Y
periaqueductal gray + N N N
substantia nigra +/++ N N N
pons 1.364
raphe nuclei + N N N
locus coeruleus +++ N N Y
mesencephalic trigeminal
nucleus
+ Y Y Y
pontine gray ++ N N N
medulla 0.635
inferior colliculus ++ Y N Y
gigantocellular reticular
nucleus
++ N N Y
magnocellular reticular
nucleus
++ N N Y
parvicellular reticular
nucleus
++ N N Y
principal sensory nucleus of
the trigeminal
++ N N Y
spinal cord 0.433 × × × ×
aColumn1: Relative normalized Gpr50 mRNA expression levels as measured by rt-PCR at E18 and week 5. Column 2: Semiquantitative evaluation
of Gpr50 protein expression after immunohistochemistry at E18 and the Week 10. Scale: ×, not investigated; −, no expression present; +, weak
expression; ++, moderate expression; +++, strong expression. Columns 3−5: Colocalization of Gpr50 and Nogo-A, Cdh8 or Abca2 as measured by
by immunohistochemistry. Scale: ×, not investigated; Y, colocalisation detected; N, no colocalization detected.
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intriguing and introduces the possibility that Gpr50 is a receptor
for these neurotransmitters, or that Gpr50 is involved in the
regulation of monoamine transmission. Given its localization
along the HPA axis, a neuropeptide ligand may also be
possible. Using diﬀerent antibodies and conditions, Gpr50
expression has also recently been reported in the dorsomedial
nucleus of the hypothalamus and median eminence of male
adult rodent, sheep, and human brain.11,24,27 In rodents,
Gpr50 expression was also found in the lateral hypothalamic
area, periventricular nucleus, and amygdala.11,24,27 In these
studies, Gpr50 appears to be expressed mainly in the ﬁbers
which may be due to the diﬀerences in antibodies, methods,
and sex of animals used.
Gpr50 Colocalization with Nogo-A, Abca2, and Cdh8.
Next we investigated whether Gpr50 colocalized with its
interactors in the E18 and adult mouse brain. The expression of
Nogo-A, Abca2, and Cdh8 was in agreement with previous
studies.28−31 In addition, control experiments show absence of
signal in secondary antibody only controls, indicating speciﬁcity
of the antibodies used (Supporting Information Figure 1B). In
the adult mouse brain, colocalization of Gpr50 and Nogo-A was
found in several areas in the hypothalamus: the subparaven-
tricular zone (Figure 5A and inset), arcuate nucleus/
ventromedial hypothalamus (Figure 5B and inset), dorsomedial
hypothalamus (Figure 5C and inset), and lateral hypothalamus
(Figure 5D and inset). In each of these areas it appears to be a
small subset of cells that express both. Colocalization of Gpr50
and Nogo-A is more widespread in the amygdala (Figure 5E
and inset), and is also found in the superior colliculus (Figure 5F
and inset) and the somatosensory cortex (Figure 5G and inset).
In the brainstem nuclei, colocalization of Nogo-A and Gpr50
could be detected in the mesencephalic trigeminal nucleus only
(Figure 5H). At E18, colocalization of Gpr50 and Nogo-A
was detected in the forebrain (Figure 6A), in the cortex at
several levels (Figure 6B, C), and in the medullary hindbrain
(Figure 6D).
Colocalization of Gpr50 and Abca2 in the adult mouse brain
was detected in several areas, including in the ventral third
ventricular ependyma (Figure 7A−C, insets) and the lateral
side of the epithelium (Figure 7B, inset). In the piriform and
Figure 3. Colabeling of Gpr50 and NeuN in the adult mouse brain. CD1 brains were ﬁxed in 70% EtOH and stained for Gpr50 and NeuN (A−E).
PIR = piriform cortex, CTX = cortex, HY = hypothalamus, Sup coll = superior colliculus, HPF = hippocampal formation, PG = pontine gray, MARV =
magnocellular reticular nucleus, PARN = parvicellular reticular nucleus, PSV = principal sensory nucleus of the trigeminal, LC = locus coeruleus.
Sections were counterstained with DAPI. Scale bar: 100 μm.
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somatosensory cortices, colocalization of Gpr50 and Abca2 is
widespread (Figure 7D, E), as is colocalization in the brain
stem nuclei of the medulla and pons, the parvicellular reticular
nucleus (PARN), gigantocellular reticular nucleus (GRN), the
principal sensory nucleus of the trigeminal (PSV), and nucleus
raphe magnus (NRM) (Figure 7F, inset, G−J). Weak
colocalization between Gpr50 and Abca2 was found in the
locus coeruleus (LC) and mesencephalic trigeminal nucleus
(Me5) (Figure 7I). As indicated by the rt-PCR results, Abca2
expression is much lower in the embryonic brain than in the
adult brain and no clear Abca2 staining could be detected at
E18.
The Cdh8 antibody detected weak expression in the adult
mouse brain (Figure 8A−C). Here Gpr50 and Cdh8 appear to
be expressed in a diﬀerent subset of cells in the median
eminence (Figure 8A) but are colocalizing in the periventricular
hypothalamus (Figure 8B) and in the amygdala (Figure 8C).
Cdh8 is also expressed in the mesencephalic trigeminal nucleus
(Figure 8D). In the embryonic brain, Cdh8 expression is
stronger and Gpr50 and Cdh8 colocalize in the dorsal forebrain
(Figure 9A), the median eminence, and third ventricular
epithelium (Figure 9B). Colocalization is also found in the
cortex (Figure 9C) and roof plate of the pontine/medullary
hindbrain (Figure 9D). Colocalization between Gpr50 and
Nogo-A, Cdh8, and Abca2 in the E18 and adult female mouse
brain by immunohistochemistry is summarized in Table 1.
Gpr50, Nogo-A, Cdh8, and Abca2 are coexpressed in several
hypothalamic (subparaventricular, dorsomedial, and arcuate
nuclei) and brain stem nuclei in the pons and medulla (PARN,
MARN, PSV, raphe nuclei) involved in the circadian and
autonomic regulation of feeding.32 Gpr50, Nogo-A, Cdh8, and
Abca2 were detected in the mesencephalic trigeminal nucleus, a
sensory ganglion containing primary sensory neurons involved
in the control of automatic (unconscious) activities of food
intake such as biting, chewing, and swallowing. Gpr50 was also
recently detected in the area prostrema in the medulla,11 an
area associated with nausea and vomiting. These links to
autonomic feeding mechanisms are interesting as Gpr50
knockout mice appear to show increased energy metabolism,
with attenuated weight gain and reduced body fat on a high-
energy diet compared to wild-type animals.10 An intronic SNP
in GPR50 was also associated and higher serum triglyceride and
lower HDL cholesterol levels.9 Through homology with the
HDL-cholesterol transporter Abca1, Abca2 has also been
implicated in lipid metabolism,33 and knockout mice have an
abnormal neurological phenotype that suggests improper
regulation of myelin precursors19 and/or sphingolipids.34
The subparaventricular zone and several medullar nuclei
incuding the LC are known to be involved in circadian control
of body temperature. Expression of GPR50 in these areas is in
agreement with a recently reported role for GPR50 in adaptive
thermoregulation and torpor.11
Gpr50, Abca2, and Cdh8 expression in the third ventricular
ependyma, median eminence, and pars tuberalis may indicate a
role in transport of lipids from the CSF/hypothalamus to the
portal blood.
Coexpression Gpr50 and interactors in the amygdala may
indicate a combined role in fear conditioning and emotional
memory35 and reward learning.36 GPR50 has been shown to
interact with TIP60 and to modulate glucocorticoid receptor
signaling,37 and Gpr50-null mice show altered corticosterone
levels,10 suggesting functions in the regulation of the HPA axis
and stress response.
A correlation of Gpr50 and Cdh8 expression in prenatal
development is interesting as Cadherin 8 is thought to play a
role in subdivisional organization of the developing brain.38−40
Cdh8 expression is implicated in the formation of functional
neural circuits involving basal ganglia-thalamocortical41,42 or
fasciculus retroﬂexus/habenulo-interpeduncular tract.43 We
found Cdh8 to be expressed in a caudal to rostral peak in the
E18 and P7 mouse brain and Gpr50 was also high in caudal
areas at E18. This may indicate a combined role of Cdh8 and
Gpr50 in the development of these areas. Gene ontology
Figure 4. Gpr50 colocalizes with noradrenergic, serotonergic, and dopaminergic markers. Adult mouse brains were ﬁxed in 70% EtOH and stained
for Gpr50 with dopamine beta hydroxylase (A), 5-HT (B−D), and tyrosine hydroxylase (E). LC = locus coeruleus, NRM = nucleus raphe magnus,
PG = pontine gray, SN = substantia nigra. Sections were counterstained with DAPI. Scale bars: 100 μm.
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analysis of the GPR50 yeast two-hybrid interactors also
indicated neural development as a key process.8
Investigating the interactions between the HPA axis and
the monoaminergic neurotransmitter systems may be key to
understanding mental illness.44 Gpr50 was found to be
highly expressed in the hypothalamus and by noradrenergic
neurons in the LC. The neurons in the LC have many
aﬀerent and eﬀerent connections often modulated by stress.45
The LC has previously been used as a model system for
stress, bipolar disorder, depression, and Alzheimer’s dis-
ease.46−48 In order to ﬁnd out more about the function
of GPR50, its function in these brain circuits must be
elucidated and the LC may be a good system in which to
study this.
The GPR50 genetic association with bipolar disorder was
found only in women,3,4 for reasons yet unclear. Previous
studies on Gpr50 expression and behavior have either used
males only10,11,16,24 or have not noted the sex of the animals,14
possibly explaining some of the diﬀerences in expression
patterns reported. Moreover, by using males, only sex-speciﬁc
behaviors relevant to mental illness may be missed as women
are more vulnerable to stress-related psychiatric disorders, such
as PTSD and major depressive disorder.49
The locus coeruleus may play a role in this, as it is a sexually
dimorphic nucleus. It develops over a longer period and is
generally larger in female rats.50,51 Swim stress-induced
activation of LC neurons was greater in female rats than in
male rats52 and was related to diﬀerential sensitivity of neurons
to corticotrophin releasing hormone (CRH) postsynaptically.
Sex-speciﬁc eﬀects on other parts of the stress response are also
signiﬁcant. Women have higher cortisol levels, and the
endocrine responses are possibly more complex with oxytocin
and female sex hormones inﬂuencing the HPA axis, ACTH,
CRH and cortisol levels during the oestrus cycle, breastfeeding,
and parturition.44,53 Although we did not investigate both sexes,
our ﬁnding of Gpr50 expression in the sexually dimorphic LC
and in the stress-associated HPA axis in female mice might
provide clues to its functioning and it may be worthwhile to
take sex diﬀerences into consideration in future (functional)
studies of GPR50.
Figure 5. Colabeling of Gpr50 with Nogo-A in the adult mouse hypothalamus. Adult CD1 brains were ﬁxed in Methacarn or 70% EtOH stained with
Gpr50 and Nogo-A (A−H). dSPZ = dorsal subparaventricular zone, ARC = arcuate nucleus, DM HY = dorsomedial hypothalamus, LA HY = lateral
hypothalamus, 3V = third ventricle, BL Amyg = basolateral amygdala, Somatos CTX = somatosensory cortex, LC = locus coeruleus, Me5 =
mesencephalic trigeminal nucleus. Scale bars: 100 μm.
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■ SUMMARY
This is the ﬁrst study investigating the developmental
expression of orphan GPR50 receptor. Expression is detected
at E13 and peaks at E18, a developmental stage important for
axon growth and guidance and synapse formation and
function.54 In addition, we identiﬁed many novel sites of
Gpr50 expression in the adult and E18 mouse brain, in neurons
in the cortex, midbrain, pons, amygdala, and in several
brainstem nuclei. We have also identiﬁed potential regions of
interaction between Gpr50 and Nogo-A, Cdh8, and Abca2. The
regions of expression suggest an involvement in neuro-
transmitter signaling and in particular energy metabolism,
thermoregulation, and stress responses, which is consistent with
previous studies of Gpr50 expression and function. These areas
of expression may provide insight into the link between
alteration of GPR50 function and risk of mental illness.
■ METHODS
Antibodies. Rabbit polyclonal antiserum CDH8 E61 was raised
against sequence derived C-terminal peptide residues 785−799:
RLGELYSVGESDKET of human CDH8. Final bleeds from immu-
nized rabbits were aﬃnity-puriﬁed against both peptides by Euro-
gentec (Double XP program), and these puriﬁed antisera were used in
all experiments. We have previously shown that anti-GPR50 (Santa
Cruz, CA, sc-50590) speciﬁcally binds overexpressed and endogenous
GPR50 in cultured mouse neurons and mouse brain fractions
(Grünewald et al., 2009). Immunocytochemistry showed predominant
expression in the cell membrane, and Western blotting indicated a
monomeric species at 67 kDa but also dimers and oligomers as in ref 8.
Others have shown staining of Gpr50 in tanycytes lining the third
ventricle in mice using this antibody.11 We also used a GPR50
blocking peptide (Santa Cruz, SC50590-P). Anti-Nogo-A (Santa Cruz,
sc-25660) speciﬁcally detects endogenous and overexpressed Nogo-A
in the ER and plasma membrane in cultured mouse neurons and
detects a band at 200 kDa in mouse brain fractions and HEK293 cell
Figure 6. Colabeling of Gpr50 with Nogo-A in the E18 mouse brain. E18 CD1 brains were ﬁxed in Methacarn and stained with Gpr50 and Nogo-A
(A−D with A′-D′ enlargements). (A, A′) Dorsal forebrain, (B, B′) frontal cortex, (C, C′) midbrain cortex, (D, D′) medullary hindbrain. Sections are
counterstained with DAPI. Scale bars: 100 μm.
ACS Chemical Neuroscience Research Article
dx.doi.org/10.1021/cn300008p | ACS Chem. Neurosci. 2012, 3, 459−472466
lysates.8 ABCA2 was ﬁrst characterized in ref 55 and speciﬁcally
detects ABCA2 by Western blotting at 270 kDa and was shown to
localize to punctate intracellular vesicles/lysosomes by immunocy-
tochemistry.
A number of antibodies were used to conﬁrm cell types and used as
cell markers: mouse anti-EEA1 (BD transduction laboratories, San
Jose, CA, 610457), mouse monoclonal anti-LAMP1 (Abcam, Cambridge
MA, ab25630), mouse monoclonal anti-Pan-cadherin (Abcam, ab6528),
mouse monoclonal anti-neuronal marker NeuN (Abcam, ab77315),
mouse monoclonal against astrocyte marker GFAP (Sigma, St. Louis,
MO, G3893), mouse monoclonal against oligodendrocyte marker O4
(R&D systems, Abingdon, U.K., MAB1326), mouse monoclonal
against tyrosine hydroxylase (Abcam, ab111), rabbit polyclonal anti-
dopamine beta-hydroxylase (DBH) (Abcam, ab43868), and rabbit
polyclonal anti-5-HT (Immunostar, Hudson, WI, 20080). Synaptic
localization was conﬁrmed using mouse monoclonal anti-PSD-95
(ABR, Golden, CO, MA1-046), mouse monoclonal anti-synaptophysin
(Sigma, S5768), and rabbit polyclonal anti-α-tubulin (Abcam,
ab4074).
Mammalian Cell Culture and Transfection. SH-SY5Y and
HEK293T cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM; Invitrogen, Paisley, U.K.) with 10% fetal bovine serum
(FBS). Cultures were kept at 37 °C with constant humidity, 95% air,
and 5% CO2. For transient transfections, lipofectamine 2000 was used
according to the manufacturer’s instructions (Invitrogen).
Immunocytochemistry. SHSY-5Y neuroblastoma cells were
seeded at 1 × 105 on glass coverslips in 12-well dishes and transfected
the following day. Cell were transfected with untagged full-length
GPR50 (GI:73909216, IOH63602 in pDEST40, Invitrogen), CDH8
(GI:16306538, IOH42822 in pDEST40), and ABCA2.55 One day after
transfection, cells were ﬁxed by incubation with ice cold 100%
methanol. Cells were washed with PBS containing 0.2% bovine serum
albumin (BSA, Sigma-Aldrich) and blocked for 30 min in PBS/BSA
with 10% serum from secondary antibody host. The following primary
antibodies in PBS/BSA were incubated for 1 h at room temperature:
anti-GPR50 (1:1000), anti-CDH8 E61 (1:1000), anti-ABCA2
(1:1000), anti-EEA1 (1:200), anti-LAMP1 (1:500), and anti-Pan-
cadherin (1:1000). Secondary antibodies Alexaﬂuor 594-conjugated
donkey anti-rabbit (1:800), 647 chicken anti-mouse (1:500), and 488
donkey anti-goat (1:500) (Molecular probes) were applied for 1 h at
room temperature. Glass coverslips were mounted onto slides using a
drop of mowiol (Sigma-Aldrich) with DAPI (Vectashield, Vector
Figure 7. Colabeling of Gpr50 with Abca2 in the adult mouse brain. Adult CD1 brains were ﬁxed in Methacarn or 70% EtOH and sections were
stained with Gpr50 and Abca2 (A−J). ME = median eminence, PT = pars tuberalis Ant HY = anterior hypothalamus, 3V = third ventricle, PIR =
piriform cortex, Somatos CTX = somatosensory cortex, PSV = principal sensory nucleus of the trigeminal, GRN = gigantocellular reticular nucleus,
PARN = parvicellular reticular nucleus, LC = locus coeruleus, Me5 = mesencephalic trigeminal nucleus, NRM = nucleus raphe magnus. Nuclei were
counterstained with DAPI. Scale bars: 100 μm.
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Laboratories, Peterborough, U.K., 2 μg/mL). Secondary antibody
controls showed no cross-reactivity between antibodies and nominal
background staining.
Co-immunoprecipitations. HEK293T cells were grown on 10 cm
dishes until 95% conﬂuent and then transfected as above. Twenty-four
hours after initiation of transfection, cells were lysed using RIPA buﬀer
(50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5%
sodium deoxycholate, plus protease inhibitors (Complete, Roche)).
Lysates were incubated on a rotary wheel for 30 min at 4 °C, and
subsequently cleared from insoluble material at 13,000 rpm at 4 °C.
The supernatant was incubated for 2 h with 3 μg of anti-GPR50.
Protein G-sepharose beads (Sigma) were added to the lysate and
incubated for 90 min. Beads were collected by centrifugation for 3 min
at 10 000 rpm and washed three times with RIPA (all at 4 °C). The
beads were resuspended in Laemmli sample buﬀer with 100 mM DTT
and boiled for 5 min. The supernatants were analyzed by Western
Blotting. PVDF membranes were incubated overnight at 4 °C with the
following primary antibodies in PBS-Tween20 with 5% milk: anti-
ABCA2 (1:1000) and anti-CDH8 (1:3000). Membranes were
incubated with a swine anti-rabbit horseradish peroxidase conjugated
secondary antibody (1:3000; DAKO A/S, Glostrup, Denmark).
Proteins were detected using chemiluminescence (ECL-Plus, Amersham
Biosciences, GE healthcare, Chalfont St. Giles, U.K.) and exposure to
X-ray ﬁlm.
Subcellular Fractionation and Western Blotting. Ten 7−10
week old female C57BL/6 mice were purchased from Harlan (U.K.).
Mice were sacriﬁced by cervical dislocation and brains were processed
for subcellular fractionation and puriﬁcation of synaptic fractions as
described previously.8 The fractions were analyzed by immunoblotting
with anti-CDH8 E61 (1:3000), anti-ABCA2 (1:1000), anti-GPR50
(1:5000), anti-PSD-95 (1:2000), anti-synaptophysin (1:10,000), and
anti-α-tubulin (1:200,000). Rabbit anti-mouse (1:2000), rabbit anti-
goat (1:5000), and swine anti-rabbit (1:3000) horseradish peroxidase
conjugated secondary antibodies (DAKO) were used, and membranes
were treated as above. This experiment was performed with three
independent samples (30 mice total).
Real-Time Reverse Transcription Polymerase Chain Reac-
tion (rt-PCR). The TissueScan Real-Time mouse developmental
cDNA panel, consisting of diﬀerent brain regions at E13, E15, E18, P7,
and adult week 5 (total 48 samples) was purchased from Origene
Technologies Inc. (lot no.11/06, Rockville, MD). The ﬁrst strand
cDNAs were synthesized from poly-A+ RNA using oligo(dT) primers
and were normalized to β-actin. The cDNAs were supplied lyophilized
and were transported frozen.
Real-time PCR using SYBR Green Supermix (100 mM KCl; 40 mM
Tris-HCl, pH 8.4; 0.4 mM of each dNTP; iTaq, DNA polymerase, 50
units/mL; 6 mM MgCl2; SYBR Green I; 20 nM ﬂuorescein, and
stabilizers; Bio-Rad Inc., Hercules, CA) was performed on the BioRad
iCycler. Primers (Supporting Information Table 1) were designed
using Primer3 software (http://primer3.sourceforge.net/), except for
β-actin, which was supplied by Origene. The linear range, correlation
coeﬃcient, and PCR eﬃciency of each primer were was determined by
producing standard curves in the Biorad iCycler, using mouse brain
cDNA as template. Reactions were performed in duplicate.
Ampliﬁcation was achieved in 35 cycles consisting of denaturation at
95 °C for 30 s; annealing at 63−65 °C for 30 s; and extension at 72 °C
for 30 s. A melting curve was obtained starting at 55 °C with 10 s
increments of 0.5 °C for 80 cycles. Each PCR reaction generated a
single amplicon as indicated by the melting temperature proﬁles. All
PCR products were also checked by gel electrophoresis to conﬁrm
correct PCR product size against a 1 kb ladder.
For analysis, the ﬂuorescence threshold value Ct (the number of
cycles required for the ﬂuorescent signal to cross the threshold (ie
exceeds background level) of each sample was calculated using the
iCycler MyiQ system software (Biorad). The relative expression of the
genes was determined using the deltaCt method, which generates raw
(not normalized) data, relative to the sample with the highest
expression. The data are further normalized using a method described
by Vandesompele et al.,56 which is equivalent to using the delta−
deltaCt method. It can be performed using the freely available geNorm
software: (http://medgen.ugent.be/∼jvdesomp/genorm/)
Normalized expression data were obtained by dividing the raw
gene-of-interest quantities for each sample by the normalization
factors, which are the geometric means of the reference genes used in
this study: β-actin, Tbp, Hmbs, and cyclophilin B. Spearman
correlations (r, (95% conﬁdence interval), signiﬁcance at p ≤ 0.05)
were performed using Graphpad Prism.
Immunohistochemistry. Female CD1 mice of approximately 10
weeks old were housed in groups of between 5 and 14 animals,
depending on cage size. Mice were kept on a 12 h light/dark cycle with
lights on at 7.00 h and were fed on SDS RM1 expanded diet with
water available ad libitum. Females were taken to the male cage and
Figure 8. Colabeling of Gpr50 with Cdh8 in the adult mouse brain. Adult CD1 brains were ﬁxed in Methacarn or 70% EtOH and stained with
Gpr50 (green) and Cdh8 (red) (A−D). VMH = ventromedial hypothalamus, ME = median eminence, 3V = third ventricle, BL Amyg = basolateral
amygdala, Me5 = mesencephalic trigeminal nucleus, LC = locus coeruleus. Nuclei were counterstained with DAPI. Scale bars: 100 μm.
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left until a vaginal plug was found. The female was then housed with
other females that were plugged on the same date. The date of the
plug was E0. Adult animals were killed by cervical dislocation.
Embryos were removed by hysterectomy and brains were directly
transferred to ice cold PBS prior to ﬁxation. Three adult female mice
and three embryonic day 18 mice were used in this study. Brains were
ﬁxed by immersion in 70% ethanol, 10% neutral buﬀered formalin
(3.7% formaldehyde) or Methacarn (60% methanol, 30% chloroform,
10% glacial acetic acid). We found that ﬁxation in 70% ethanol or
Methacarn resulted in improved immunoreactivity and cell morphol-
ogy compared to 4% formaldehyde or 10% formalin. E18 brains were
ﬁxed for 4 h at room temperature and adult brains for 16−18 h at
4 °C. Brains were then transferred to 70% ethanol and stored at −20 °C
until further processing. Brains were embedded in paraﬃn wax and cut
into 6 μm sections on a Leica microtome onto gelatin coated
superfrost plus slides (Thermo Fisher, Waltham, MA). Six coronal
sections per animal from three individual 10−13 week old CD1 female
and E18 mouse brains were processed for immunoﬂuorescent
detection of Gpr50 and interactors. Intact coronal sections
corresponding to approximately Bregma −0.655 mm, −1.455 mm,
−2.88 mm, −3.58 mm, −4.655 mm, and −5.555 mm were chosen
from each animal to cover all brain regions evaluated. After sectioning,
slides were dried at 37 °C overnight. Sections were dewaxed in xylene
and rehydrated in 100% and 70% EtOH. Before staining, formalin-
ﬁxed sections were incubated in picric acid for 20 min and antigen
retrieval was performed by microwave boiling slides in 50 mM borate
buﬀer pH 8.0 for 15 min.57 For chromogenic detection, sections were
incubated in 3% H2O2 (Sigma) for 10 min to quench endogenous
peroxidises, followed by three washes with PBS. Sections were loaded
into Shandon Sequenza slide racks. Tissues were permeabilized in
0.1% triton X-100 (Sigma) in PBS for 30 min, washed twice in PBS/
0.02% BSA, and incubated in 6 M guanidine hydrochloride for 10
min.58 After washing the slides 3× with PBS/BSA, sections were
incubated in 10% serum from secondary antibody host in PBS/BSA
for 30 min. Slides were incubated with the following primary
antibodies in PBS for 16−18 h: GPR50 (1:50), Nogo-A (1:100),
CDH8 E61 (1:100), ABCA2 (1:500), 5-HT (1:250), NeuN (1:1000),
GFAP (1:500), O4 (1:500), dopamine beta-hydroxylase (DBH,
1:250), and tyrosine hydroxylase (TH, 1:250). To assess speciﬁcity
of staining, brain sections were incubated with a mix of GPR50
antibody and GPR50 blocking peptide. GPR50 antibody (4 μg/mL)
and blocking peptide (16 μg/mL) were preincubated for 1 h at room
temperature before addition to the slides. In addition, controls
whereby the primary antibody is omitted were performed for Gpr50,
Figure 9. Colabeling of Gpr50 with Cdh8 in the E18 mouse brain. E18 CD1 brains were ﬁxed in Methacarn and stained with Gpr50 and Cdh8
(A−D with A′−D′ enlargements). A, A′: Dorsal forebrain, B, B′: hypothalamus and third ventricle, C, C′: cortex, D, D′: roofplate of the pontine/
medullary hindbrain. 3V =third ventricle, ARC = arcuate nucleus, ME = median eminence. Sections are counterstained with DAPI. Scale bars: 100 μm.
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Nogo-A, Cdh8, and Abca2 staining. Slides were washed three times
with PBS/BSA before and after incubation with secondary antibodies.
For chromogenic detection of proteins, biotinylated rabbit anti-goat
(DAKO) was used at 1:500 for 30 min followed by ABC Elite (Vector
Laboratories) for 30 min. Proteins were visualized by incubation with
DAB (Vector Laboratories). After counterstaining in Harris hema-
toxylin and lithium carbonate, slides were dehydrated in 70% and
100% ethanol and xylene. Coverslips were then mounted onto slides
using pertex. For ﬂuorescent detection, slides were incubated for 1 h
with donkey anti-goat (Alexaﬂuor 488, Invitrogen) and donkey anti-
rabbit (Alexaﬂuor 594) or donkey anti-mouse (594) in PBS/BSA.
Coverslips were mounted onto slides using Vectashield w/DAPI
(Vector Laboratories).
Imaging and Semiquantitative Evaluation of Regional
Expression. Confocal images of neurons were captured sequentially
(line) on an Olympus Fluoview 1000 (UPlanSApo 10×/0.4, 20×/
0.75, or 60×/1.35 (oil) objectives) or Zeiss LSM510 (Plan Neoﬂuar
20×/0.50 or 40×/0.75 and Plan-Apochromat 63×/1.4 (oil)
objectives) confocal laser-scanning microscope at image size 1024 ×
1024 using Kalman ﬁlter mode 3. Bright-ﬁeld images were taken on
an Olympus BX light microscope ﬁtted with 10×, 20×, and 40×
objectives. Secondary antibody controls showed no cross-reactivity
between antibodies and nominal background staining. Sections were
compared to the adult coronal reference atlas of the Allen Brain Atlas:
http://mouse.brain-map.org. For the visual evaluation of relative
expression levels, each brain region was evaluated for DAB and
ﬂuorescence staining intensity based on the following scale: ×, not
investigated; −, no expression present; +, weak expression; ++,
moderate expression; +++, strong expression.
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